A randomized, double blind, placebo controlled, parallel group, pilot study of 1:1 and 20:1 ratio of formulated GWP42003: GWP42004 plus GWP42003 and GWP42004 alone in the treatment of dyslipedemia in subjects with Type 2 diabetes.
2022-06-28
عنوان الدراسة
A randomized, double blind, placebo controlled, parallel group, pilot study of 1:1 and 20:1 ratio of formulated GWP42003: GWP42004 plus GWP42003 and GWP42004 alone in the treatment of dyslipedemia in subjects with Type 2 diabetes.
داعم الدراسة
GW
دواء الدراسة
Cannabidiol & Tetrahydrocannabivarin
رقم بروتوكول الدراسة
GWZMD1190
حالة الدراسة
Rejected
موقع الدراسة
KAUH-R
مرحلة الدراسة
2A
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.